ArticleAntimicrobial agents and chemotherapy2013

Resistance studies of a dithiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems.

Hui-Mei Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.